|
XRCC5 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.795600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.645600E-01 |
| Normal-vs-Stage2 |
4.978800E-01 |
| Normal-vs-Stage3 |
1.716840E-01 |
| Normal-vs-Stage4 |
8.071400E-01 |
| Stage1-vs-Stage2 |
4.354200E-01 |
| Stage1-vs-Stage3 |
1.445440E-01 |
| Stage1-vs-Stage4 |
8.402600E-01 |
| Stage2-vs-Stage3 |
7.044400E-01 |
| Stage2-vs-Stage4 |
7.494000E-01 |
| Stage3-vs-Stage4 |
4.889000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.952400E-01 |
| Normal-vs-AfricanAmerican |
5.099000E-01 |
| Normal-vs-Asian |
8.701600E-01 |
| Caucasian-vs-AfricanAmerican |
7.860800E-01 |
| Caucasian-vs-Asian |
7.890000E-01 |
| AfricanAmerican-vs-Asian |
7.120000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.031600E-01 |
| Normal-vs-Female |
3.235800E-03 |
| Male-vs-Female |
1.558360E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.348200E-01 |
| Normal-vs-Extreme_Weight |
3.339200E-01 |
| Normal-vs-Obese |
1.842390E-01 |
| Normal-vs-Extreme_Obese |
7.171200E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.971200E-01 |
| Normal_Weight-vs-Obese |
3.317200E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.272200E-01 |
| Extreme_Weight-vs-Obese |
2.572100E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.425800E-01 |
| Obese-vs-Extreme_Obese |
3.293800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.870200E-02 |
| Normal-vs-Age(41-60Yrs) |
7.744100E-02 |
| Normal-vs-Age(61-80Yrs) |
4.225000E-01 |
| Normal-vs-Age(81-100Yrs) |
5.856400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.152990E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.480400E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.693700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.323900E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.618420E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.580200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.841000E-01 |
| Normal-VS-Type2 PRCC |
4.290800E-01 |
| Normal-VS-KIRP CIMP |
1.207580E-02 |
| Normal-VS-Unclassified PRCC |
1.035550E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.914380E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.957800E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
8.554200E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.244670E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
2.634300E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.175770E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.394790E-01 |
| Normal-vs-N1 |
1.338440E-02 |
| Normal-vs-N2 |
5.261900E-02 |
| N0-vs-N1 |
1.242700E-03 |
| N0-vs-N2 |
4.344400E-02 |
| N1-vs-N2 |
7.828200E-01 |
|
|
